A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

Ulrik Lassen, Lars Henrik Jensen, Morten Sorensen, Kristoffer S Rohrberg, Zaza Ujmajuridze, Anders Jakobsen

22 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab